Bo Söderpalm and Andrea de Bejczy on alcohol use disorder

from The Lancet Regional Health Europe in conversation with · host Lancet

Alcohol use disorder is a major public health issue affecting approximately 100 million people worldwide, yet treatment options remain very limited. Bo Söderpalm and Andrea de Bejczy join Rafael Cardoso from The Lancet Regional Health - Europe to discuss their trial, which for the first time combined administration of varenicline and bupropion for alcohol use disorder. Read the full article: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00102-4/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanepe

Episode metadata supplied by the publisher feed · Published Jul 21, 2025

Embed this episode

Attribution link and audio player

Ready to play

Bo Söderpalm and Andrea de Bejczy on alcohol use disorder

0:00 16:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lancet Regional Health Europe in conversation with?

This episode is 16 minutes long.

When was this The Lancet Regional Health Europe in conversation with episode published?

This episode was published on July 21, 2025.

Can I download this The Lancet Regional Health Europe in conversation with episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!